🇺🇸 FDA
Pipeline program

OCALIVA, Placebo for Bezafibrate, Bezalip Mono, Placebo for Obeticholic Acid, Bezalip, OCALIVA

747-213

Phase 2 small_molecule active

Quick answer

OCALIVA, Placebo for Bezafibrate, Bezalip Mono, Placebo for Obeticholic Acid, Bezalip, OCALIVA for Primary Biliary Cholangitis (PBC) is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Primary Biliary Cholangitis (PBC)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials